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Abstract
Due to the recent widespread application of nanomaterials to biological systems, a careful consideration of their physiological
impact is required. This demands an understanding of the complex processes at the bio–nano interface. Therefore, a comprehensive
and accurate characterization of the material under physiological conditions is crucial to correlate the observed biological impact
with defined colloidal properties. As promising candidates for biomedical applications, two SiO2-based nanomaterial systems were
chosen for extensive size characterization to investigate the agglomeration behavior under physiological conditions. To combine the
benefits of different characterization techniques and to compensate for their respective drawbacks, transmission electron
microscopy, dynamic light scattering and asymmetric flow field-flow fractionation were applied. The investigated particle systems
were (i) negatively charged silica particles and (ii) poly(organosiloxane) particles offering variable surface modification opportuni-
ties (positively charged, polymer coated). It is shown that the surface properties primarily determine the agglomeration state of the
particles and therefore their effective size, especially under physiological conditions. Thus, the biological identity of a nanomaterial
is clearly influenced by differentiating surface properties.
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Introduction
Accurate characterization of nanomaterials
for use in biological environments
Since the huge surface area to volume ratio of nanoparticles
(NPs) provides an enormous reactive interface between the
particle and its local environment, the properties of materials
with identical chemical composition can differ significantly
depending on whether the compound is applied as bulk ma-
terial or as nanomaterial (NM). The presence of NMs in daily
life products, the need for a health risk estimation that arises
from this presence and potential applications in the field of
biomedicine demand an investigation of the bio–nano interface
[1-4].
As an essential part of assessing medical benefits or potential
harms of nanomaterials, a comprehensive and accurate charac-
terization of the material is inevitable to be able to clearly corre-
late the observed biological impact with defined colloidal prop-
erties [5-7]. There is a multitude of crucial NP properties that
could be addressed in such a characterization, for example, size,
size distribution, shape, crystal structure, chemical composition,
surface area, functional groups, charge or porosity [8].
However, since an exhaustive characterization of nanomaterials
is complex and therefore both time- and cost-consuming, a
customized characterization focusing on the objective of the
study is recommended [9]. To ensure comparability of experi-
ments, standardization of characterization methods must be
developed and applied [10].
Since nanomaterials gain more and more importance as subjects
of in vitro and even in vivo studies, a proper characterization of
the NPs especially in biologically relevant media becomes
crucial because pristine colloidal properties can alter therein.
This is particularly valid in the presence of proteins [11]
because NPs tend to form a protein corona [12,13] that is
considered to mediate cellular responses [14] and uptake path-
ways [15,16]. Depending on the nature of colloidal stabiliza-
tion, the formation of a protein corona and/or even the condi-
tions of physiological salinity can furthermore induce agglom-
eration. This affects particle characteristics especially with
respect to particle size and size distribution, which can influ-
ence the biodistribution, circulation time, intracellular traf-
ficking, clearance or uptake mechanism [17].
Within this paper, we present the size characterization of two
SiO2-based nanomaterials: silica nanoparticles that are
electrostatically stabilized by negative surface charges and
poly(organosiloxane) nanoparticles that were modified to carry
positive charges and/or a polymer shell. We demonstrate a
combination of carefully chosen characterization techniques,
that is, transmission electron microscopy (TEM), multiangle
dynamic light scattering (DLS) and asymmetric flow field-flow
fractionation (AF-FFF). By combining the strengths of each of
the individual techniques, their drawbacks are compensated for
and a comprehensive characterization in physiological media is
possible. As a result, it is shown that differences in the agglom-
eration state and therefore in size were observed under physio-
logical conditions both in presence and in absence of serum
proteins. This is especially relevant with regard to in vitro
studies.
Characterization techniques
As mentioned, only by combining different characterization
techniques can one compensate for the drawbacks of each tech-
nique. This section gives a short introduction into each of the
techniques that were applied in this study. Special emphasis is
placed on the advantages and disadvantages [9,18,19].
TEM: Transmission electron microscopy (TEM) is a widely
applied technique that uses a focused electron beam to image
nanometer-sized structures [20]. Within a very short time, TEM
gives at least a quantitative overview over the most important
properties of the sample (shape, size and size distribution).
However, analysis of TEM data is always based on single-
particle measurements. For a precise and reliable quantification
of the mentioned characteristics from TEM images, care must
be taken in the statistical evaluation of TEM data. A second
disadvantage arises from the fact that TEM requires vacuum
conditions to reach a reasonable resolution. Thus, particulate
samples cannot be investigated in dispersed state and are
commonly prepared by dry preparation. This involves placing a
droplet of the particle dispersion on a carbon- or polymer-
coated copper grid then the solvent is allowed to evaporate.
However, this procedure leads to preparation artifacts that
mainly pertain to the arrangement of the particles. Therefore,
standard TEM is useful to obtain information about the pristine
state of particles but does not provide information about the
hydrodynamic properties of a sample, for example, its agglom-
eration state in a physiologically relevant medium [18,21].
The latter question can only be addressed by cryogenic trans-
mission electron microscopy (cryo-TEM). For sample prepar-
ation, the method of plunge freezing is applied here: The vitrifi-
cation of aqueous samples in liquid propane or ethane prevents
the water film that covers the grid from crystallizing and leads
to a fixation of the state in solution. The investigation under
frozen–hydrated conditions allows the visualization of a partic-
ulate sample under physiological conditions in a state that is as
close as possible to its native state in solution [21-23].
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However, as cryo-TEM investigations require an experienced
operator and are both cost- and time-consuming, the method is
far from becoming a standard technique.
DLS: In dynamic light scattering (DLS), the fluctuations of the
intensity of light scattered by a colloidal dispersion are
observed over time and the analysis of the self-correlated data
yields information about the hydrodynamic radius (Rh) of the
sample. The fluctuations in scattering intensity initially origi-
nate from the Brownian motion of the particles [24,25]. For data
analysis, these fluctuations are transferred to the autocorrela-
tion function, g1(τ), which is a mathematical description of how
the scattering signal at a given time t is related to the signal at a
later time, t + τ. Information about the self-diffusion coefficient
(Ds) is gained from the decay of the autocorrelation function by
applying the so-called Siegert relation. By subsequent applica-
tion of the Stokes–Einstein equation, the hydrodynamic size can
be calculated from Ds [26].
DLS is a very powerful characterization technique as it yields
absolute values for an ensemble of particles. Additionally, it
allows for the investigation of the properties of the particles in
solution, even under physiologically relevant conditions. There-
fore, a multitude of DLS setups is commercially available
today, most of them operating at one single scattering angle.
Nevertheless, there is a clear benefit of using a multiangle setup
for the investigation of complex samples and/or complex ques-
tions, such as the investigation of the agglomeration behavior of
colloids under physiological conditions. While addressing ques-
tions of such complexity, the necessity for a high level of exper-
tise in light scattering data acquisition, evaluation, and interpre-
tation arises from the fact that several challenging issues can
occur [27]. First, in the case of samples being not truly
monodisperse, one must extrapolate q2 → 0 to reveal the true
value of the inverse z-average of the sphere-equivalent hydro-
dynamic radius, . As the scattering vector, q, mainly
depends on the scattering angle, θ, this requires angular-depen-
dent measurements. Otherwise (when using a single-angle
setup), only apparent size values are obtained and with
increasing polydispersity, these can differ significantly from the
true size [18]. Second, as the scattering intensity scales with the
sixth power of particle size (I ~ R6), the detection of smaller
particles is hampered in the presence of larger particles. This
necessitates the removal of dust particles (if the data are not
post-processed) and makes the separation of fractions of multi-
modal samples (e.g., agglomerates alongside with non-agglom-
erated particles) a very sophisticated task [28]. Third, the µ2
value that results from cumulant analysis allows for an estima-
tion of the width of the distribution of the self-diffusion coeffi-
cients and is generally used to assess polydispersity from DLS
data. As a convention, the μ2 values at a scattering angle of 90°
are usually given. Roughly estimated, samples with μ2 values
smaller than 0.05 are considered to be monodisperse, whereas
samples with μ2 values greater than 0.2 are considered to be
polydisperse [29]. Calculations of size distributions and poly-
dispersity values from μ2 should be treated with care since non-
Gaussian size distributions as well as disturbances can distort
the derived distributions. When measuring in deionized water,
such a disturbance could originate from long-range, inter-
particle interactions leading to artifacts in the angular depen-
dency of the apparent diffusion coefficients. This is the
so-called structure factor, S(q) [30,31].
AF-FFF: Asymmetric flow field-flow fractionation (AF-FFF)
describes a quasi-chromatographic, semi-preparative particle
separation method and is the best known and best established
representative of the versatile field-flow fractionation (FFF)
family [32-36]. As hydrodynamic sizes and size distributions of
particles ranging from 1 nm to several µm can be analyzed,
AF-FFF is a powerful tool for sample separation and size char-
acterization of nanoparticles both in aqueous and in organic
solution. The separation is realized by a ribbon-like fractiona-
tion channel in which the sample is transported by the carrier
liquid that generates a lamellar flow profile. This axial flow is
superposed by a homogeneous drainage of the carrier liquid at
one channel border, which induces a drift of the sample towards
the accumulation membrane where slow axial flow velocities
are present. Retention will occur according to the average dis-
tance of the sample to the accumulation wall, which is deter-
mined by the cross flow induced drift and the size-dependent
diffusion coefficient of the particles. Thus, particles separate
according to their hydrodynamic properties [37]. Typically, the
hydrodynamic radius can be determined by measuring the reten-
tion time of size standards and applying the calibration data to
the elugram of the sample [38]. Since particle–particle interac-
tions as well as particle–membrane interactions cannot be
neglected, size determination in AF-FFF is not absolute [39].
The mentioned interactions are strongly affected by the concen-
tration and the type of the electrolyte that is added to the eluate.
When increasing the salinity of the dispersant, electrostatic
repulsions of colloids are reduced by decreasing the Debye
screening length, κ−1, as described by the DLVO theory [40].
Additionally, specific ion phenomena arise from different polar-
izabilities and Pearson acidities of the ions, leading to a varia-
tion of ion–solvent interactions [39]. Specific ion properties are
summarized in the Hofmeister or lyotropic series [41,42], which
orders ions according to the magnitude of their destabilizing
effect on colloidal dispersions. Nevertheless, small amounts of
salt should be added to the eluate in AF-FFF to minimize elec-
trostatic repulsion [43]. For application in the fields of the bio-
nano sciences, physiological salt contents are of special interest.
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However, little success was achieved when operating AF-FFF
setups at 150 mM salinity. Practically, an upper concentration
limit of 50 mM NaCl was found [44]. This can be attributed to
the fact that hydrophobic interactions are present at higher salt
concentrations, leading to reversible or irreversible sample
adsorption onto the membrane. Peak broadening and peak
asymmetry are observed consecutively [45] as well as a loss in
the recovery rate [46,47]. By coupling of a variety of online
detectors to the FFF instrument, an extensive sample characteri-
zation is possible, providing a comprehensive analysis with
emphasis on single fractions. Relevant online detectors are
based on fluorescence detection and UV absorbance to deter-
mine retention times and for an appropriate concentration
determination. Also, absolute size characterization by static
light scattering (multiangle laser light scattering, MALLS),
dynamic light scattering [48,49], or mass spectrometry (induc-
tively coupled plasma mass spectrometry, ICP-MS) [50] can be
applied.
Silica and poly(organosiloxane) nanoparticles
Although both silica and poly(organosiloxane) (POS) nanoparti-
cles are based on silicon dioxide (SiO2) as building blocks and
are chemically closely related, the two systems exhibit different
properties. These different properties result in different fields of
applications. “Simple” (non-modified) silica particles have been
widely used for decades as additives in the tire and construc-
tion industry, in cosmetics, and even in food [51]. Furthermore,
both silica and siloxane particles are promising candidates for
applications in the field of nanomedicine. In particular, the
poly(organosiloxane) particles offer high versatility and flexi-
bility with regard to architecture, composition and functional-
ization. Hence, they are highly suitable for tailored biomedical
applications, for example, as drug carrier systems, as agents in
hyperthermia, or as contrast agents for magnetic resonance
imaging (MRI) [52,53].
Silica nanoparticles: As most of the common crystalline SiO2
particles are not in the nanometer-size region, we will focus on
amorphous silica nanoparticles (aSNPs) in the following
section. Based on their preparation procedure, aSNPs can be
divided into three main subclasses [54]:
1. Silica sols (also called “colloidal silica”) are manufactured on
the industrial scale by acidification of waterglass (aqueous solu-
tions of alkali silicates, e.g., Na2SiO3, Na4SiO4). Typically, this
neutralization is performed by using ion exchange resins where
particle sizes of around 5 to 500 nm in diameter can be realized
[55-57].
2. Pyrogenic silica (also referred to as “fumed silica”) is
produced on the industrial scale as well. By pyrolysis of, for
example, silicon tetrachloride, primary particles with diameters
less than 50 nm are obtained. These merge irreversibly into
aggregates with diameters between 250 nm and a few tens of
micrometers [58,59].
3. The third synthesis route involves the hydrolysis and conden-
sation of silicic acid esters (mostly tetraethyl orthosilicate,
TEOS) under basic alcoholic conditions. It was first described
by W. Stöber in 1968 [60] and gives well defined particles with
sizes of around 20 to 5,000 nm. Numerous improvements allow
for the synthesis of core–shell particles, of dye-labelled parti-
cles, or of particles with defined surface functionalities [61-64].
Furthermore, the reaction principle of the Stöber synthesis is
also applied for the preparation of mesoporous silica nanoparti-
cles (MSN) [65].
With respect to particle size distributions, silica sols and Stöber
particles are typically relatively monodisperse. Standard devia-
tions are found in the range of 15 to 30% for silica sols and in
the range of 5 to 15% for Stöber particles. For both methods,
this depends on the synthesis conditions and on the particle size.
In contrast, pyrogenic silica particles exhibit broad size distribu-
tions. Due to the differences in the preparation procedures, the
three silica particle types exhibit different properties beyond the
realizable particle size and particle size distribution, for
example, with respect to density and surface porosity
[54,56,58,59].
Silica nanoparticles are already widely investigated. Therefore,
they are an ideal reference system to demonstrate the potential
of the combination of characterization techniques that we have
chosen. Parts of the characterization data acquired within this
study were also used as the basis for nanotoxicology studies
[51]. As reported there, NexSil20 is a commercially available,
colloidal silica without surface modification. Keeping in mind
its application to nanotoxicology studies, this system was
chosen due to the fact that colloidal silica is used for most real
life applications of silica nanoparticles.
Poly(organosiloxane) nanoparticles: Poly(organosiloxane)
NPs are synthesized in an aqueous dispersion by co-conden-
sation of mixtures of dialkyldialkoxysilanes and alkyltri-
alkoxysilanes in the presence of a surfactant. By sequential
addition of mixtures with different ratios of bi- to tri-functional
monomers, different crosslinking densities can be realized and
the formation of systems with core–shell architecture is
possible. By introducing monomers with functional groups,
each of the structural elements (core, shell or one of multiple
shells) can be functionalized independently [66-68]. The
addition of a chloromethylphenyl co-monomer for instance
allows for selective fluorescence labeling of the core [69,70].
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To obtain an unmodified, hydrophobic surface, the reactive
residues on the shell are saturated with a trialkylalkoxysilane. In
contrast, the application of appropriately functionalized
monomers yields either an unreactive (but functionalized)
particle surface, or a surface which is covered with reactive
groups that can be further converted in subsequent reactions
(e.g., to achieve water solubility) [53].
Particle diameters in the range of 15 to 150 nm with polydisper-
sity values comparable to those of Stöber silica particles are
possible. Due to the incorporation of organic residues into the
siloxane network, the poly(organosiloxane) NPs have a lower
density than Stöber particles (typical values on the order of 1.1
to 1.5 g/cm3). Since the synthesis allows for a very selective
functionalization of any particle compartment, POS particles
show higher versatility with respect to the variety of possible
functionalizations. This makes it possible to change the polarity
of the particles. Due to that, the poly(organosiloxane) NPs are a
suitable system for a very interesting application in the field of
nanotoxicology research: the investigation of the interaction of
nanoparticles with the components of the alveolar surfactant
film [71-73]. As the lung surfactant is the first barrier that
inhaled nanoparticles encounter after passing the respiratory
tract [74], interactions with this barrier are crucial in inhalation
toxicology.
The preparation of the poly(organosiloxane) particles that we
report on is based on previously described syntheses by our
group [66,69]. These procedures were extended as follows [75]:
First, core–shell particles with a dye-labelled core were synthe-
sized by using the basic synthesis route. The shell was function-
alized with amine groups (–NH2) by addition of N-(6-amino-
hexyl)aminopropyltrimethoxysilane (AHAPS) to the monomer
mixture for the shell. Reactive residues on the surface were
saturated with ethoxytrimethylsilane by application of the usual
two-stage endcapping procedure. Due to the polar end groups in
the shell, the particles are soluble in polar organic solvents and
the second stage of the endcapping procedure was performed
in  methanol .  Subsequent ly ,  amine  func t iona l ized
poly(organosiloxane) nanoparticles POS-NH2 in water were
obtained after dialysis in 2-(N-morpholino)ethanesulfonic acid
(MES) buffer and water.
As shown in Scheme 1, the surface of the particles can be
loaded with physical charges by alkylation of the amine groups
to guarantee the positive charge of the surface independent from
salt conditions. For this purpose, POS-NH2 nanoparticles in
methanol were reacted with ethyl iodide and 2-iodoethanol
yielding the quaternized particles POS-NH2Q1 and
POS-NH2Q2. Alternatively, the amine groups can be used for
grafting reactions with polymers in a “grafting onto” approach
leading to a shift of the stabilization mechanism towards
steric stabilization. Hence, a carboxy (–COOH) terminated
poly(ethylene glycol) (PEG, molecular weight ca. 2 kDa)
was reacted through a coupling reaction mediated by
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) in
methanol (PEG@POS-NH2). Finally, the combination of both
modification steps was achieved, which yields sterically stabi-
lized particles with additional charges within the polymer shell
(PEG@POS-NH2Q1 and PEG@POS-NH2Q2). To accomplish
this, the POS-NH2 nanoparticles were first PEGylated and then
the remaining ammonium groups were quaternized. As all of
the described modification steps are carried out in methanol, a
dialysis step is needed at the end of each synthesis to transfer
the particles into water. The possibilities for modifications of
the AHAPS functionalized poly(organosiloxane) nanoparticles
are summarized by a schematic illustration of the synthesis
routes in Scheme 1.
Results and Discussion
Comparison of the agglomeration behavior of
silica and siloxane nanoparticles
In the following, the results of extensive size characterization of
the synthesized siloxane particles under non-physiological as
well as under physiological conditions are described and
compared to the data obtained for the negatively charged silica
NPs. Such studies are important as the utilization of a well-
characterized material with defined properties is necessary to be
able to correctly interpret the results of any study on the physio-
logical impact of nanomaterials (e.g., in nanotoxicology or with
regard to potential biomedical applications).
Characterization under non-physiological conditions
Both the silica as well as the poly(organosiloxane) nanoparti-
cles were first analyzed by TEM to get a quick overview of the
properties of the samples (Figure 1). The TEM pictures show a
nearly spherical shape for both particle types. By manual image
analysis, the radius of the silica particles was estimated to be
15.4 ± 2.2 nm (±14%, analysis of over 100 particles) and the
radius of the POS particles was estimated to be 7.8 ± 1.3 nm
(±17%, analysis of over 60 particles). For a more reliable size
determination from TEM images, more sophisticated analysis
routines should be applied. Specifically, this should include the
analysis of more particles (>500) and, if possible, an automated
image analysis to increase reproducibility [76]. The silica parti-
cles are found either as single particles or in smaller groups,
whereas the siloxane particles are found in large clusters or
arranged in layers. In contrast, the characterization of the hydro-
dynamic properties in the following does not show large
agglomerates for these samples under non-physiological condi-
tions. This provides evidence that dry preparation of colloidal
samples induces preparation artifacts. During all of the modifi-
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Scheme 1: Schematic illustration of the synthesis routes for the preparation of quaternized and/or PEGylated poly(organosiloxane) nanoparticles
starting from AHAPS-modified particles.
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Table 1: Hydrodynamic radius, Rh, and μ2 values in different media for the samples discussed in this publication. NexSil20 NPs are commercial silica
nanoparticles, POS-NH2 NPs are amine-modified poly(organosiloxane) particles at different modification stages: bare, quaternized, PEGylated and
PEGylated + quaternized. DLS measurements were performed with an ALV multiangle setup, all samples were filtered after mixing of the compo-
nents, and radii were determined either by applying a biexponential fitting function (non-agglomerated samples) or by conducting a multicomponent
analysis in the cases where proteins were present [28]. DLS analysis of the pure protein mixture in RPMI cell culture medium (RPMI + 5% FCS) yields
an average hydrodynamic radius of 9.2 nm (μ2: 0.16). Furthermore, the results of zeta potential (ZP) measurements in low salt containing water are
shown; these measurements were performed by using a Malvern Zetasizer.
Water (5 mM NaBr) RPMI RPMI + 5% FCS
ZP / mV Rh / nm μ2(90°) Rh / nm μ2(90°) Rh / nm μ2(90°)
NexSil20 -40 17.1 0.11 17.6 0.09 91 0.11
POS–NH2 31 13.5 0.11 prec.a agglom.b (128)
POS–NH2Q1 27 15.6 0.29 prec.a agglom.b (219)
POS–NH2Q2 32 15.8 0.27 prec.a agglom.b (183)
PEG@POS–NH2 14 22.2–41.5 0.33 18.6 0.13 44 0.32
PEG@POS–NH2Q1 12 18.9 0.27 110 0.19 57 0.34
PEG@POS–NH2Q2 16 21.4 0.26 111 0.22 69 0.32
a”prec.” indicates that the sample precipitated macroscopically; b”agglom.” indicates that agglomeration occurred and the agglomerates were nearly
as big as the specified filter pore size of 450 nm; the corresponding mean radius values are given in parenthesis. In the other cases (radius values not
in parenthesis) measurements were spot-checked for filtration loss by comparison with results obtained after filtration through filters of larger pore size
(>2 μm).
cation steps of the POS-NH2 particles, organic or polymeric
materials were introduced. Due to the lower contrast of carbon
atoms compared to silicon, none of these modifications can be
visualized by TEM, at least without the application of contrast
agents. As staining procedures might cause additional artifacts
and furthermore also lead to an increase in preparation time, no
staining was applied here and for the POS particles the TEM
investigation is only useful at the first stage of the modification
procedure.
Figure 1: TEM micrographs of NexSil20 and POS-NH2 nanoparticles
after dry preparation from an aqueous dispersion.
To compensate for the mentioned drawbacks of the TEM data
evaluation, angular-dependent DLS measurements were
performed. The results are summarized in Table 1. To evaluate
the DLS data, bi-exponential fitting functions were primarily
used. Additionally, cumulant analyses were performed at scat-
tering angles of 90° to derive μ2 values as a qualitative measure
for polydispersity. In the third column, the hydrodynamic radii
that were obtained for measurements in deionized water are
shown. One potential problem of measuring colloids in deion-
ized water was already described above. That is, the inter-
particle interactions can cause artifacts in the angular depen-
dency of the apparent diffusion coefficients [26]. Additionally,
ionic impurities and dissolved carbon dioxide cause the pres-
ence of ions in minor amounts leading to the fact that salinity is
purely defined. Therefore, the addition of small amounts of salt,
for example, 5 mM NaBr as chosen here, does not disturb the
measurement, but rather promotes constant salinity.
NexSil20: DLS of NexSil20 yielded a hydrodynamic radius of
17.1 nm. The μ2 value of 0.11 indicates that NexSil20 is not
monodisperse but still has a narrow size distribution. The
measured hydrodynamic radius is marginally larger compared
to TEM size determination. From these findings we conclude
that there are a very small number of agglomerates present in
the sample. Due to the R6 dependence of the scattering inten-
sity (see above), a small number of agglomerates have a compa-
rably high impact on the mean value in DLS, whereas in TEM,
one is not able to detect agglomerates due to the fact that the
arrangement of the particles is influenced by the preparation.
Zeta potential (ZP) determination in water containing small
amounts of salt (5 mM NaBr) yielded a value of −40 mV, which
clearly shows the negative surface charge that is responsible for
Beilstein J. Nanotechnol. 2014, 5, 1774–1786.
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Figure 2: Apparent self-diffusion coefficients (Ds,app) from angular-dependent DLS measurements with respect to the squared scattering vector (q2)
for the samples POS-NH2 and PEG@POS-NH2. In contrast to POS-NH2, the sample PEG@POS-NH2 shows an angular dependence of the Ds,app
values and a linear fit of only the large scattering angles (θ < 120°) would disregard a second fraction of larger particles. This is a clear indication of
agglomeration and an explanation for the large polydispersity value of this sample. Furthermore, this example nicely illustrates that especially for poly-
disperse samples only the extrapolation q2 → 0 can yield true values for Ds (and similarly also for Rh).
the colloidal stability of the dispersion. Generally, the absolute
value of the zeta potential decreases under conditions of high
salinity, which are predominant in cell culture medium. For
example, for NexSil20, a zeta potential value of −20 mV is
found. However, under conditions of physiological salinity, zeta
potential determinations based on electrophoretic mobility
measurements should be treated with great care. As they are
influenced by a multitude of factors, such as surface charge,
salinity and by the interactions that are present in the colloid,
the applied models to derive zeta potential values from elec-
trophoretic mobility become inadequate [77].
POS-NH2: The sample POS-NH2 yielded a hydrodynamic
radius of 13.5 nm and a μ2 value of 0.11. After alkylation with
ethyliodide or, alternatively, with 2-iodoethanol (POS-NH2Q1
and POS-NH2Q2, respectively) an increase of around 2 nm in
hydrodynamic radius was observed. The distinctly higher μ2
values of 0.29 and 0.27 for the quaternized samples are presum-
ably caused by a minor fraction of agglomerates. Agglomera-
tion might be induced here by the change of the surface prop-
erties during the quaternization procedure. Thus, the higher μ2
values reveal a decrease in colloidal stability of the samples
after quaternization. Zeta potential measurements show a rather
constant value of approximately +30 mV in 5 mM NaBr for all
three samples indicating that, at least under low salt conditions,
the degree of quaternization does not influence the charge of the
particles.
PEG@POS-NH2: With the introduction of PEG, the mecha-
nism of colloidal stabilization is changed towards steric stabi-
lization and colloidal stability is expected to increase. However,
the DLS measurement of the resulting sample PEG@POS-NH2
revealed a hydrodynamic radius of 41.5 nm and μ2 values of
0.33. Additionally, in contrast to the non-PEGylated sample
POS-NH2, a significant dependence of the apparent diffusion
coefficients on the scattering angle was observed for the sample
PEG@POS-NH2. This is shown in Figure 2 in which the
apparent self-diffusion coefficients, DS,app, are plotted against
the (squared) scattering vector q (which correlates to the scat-
tering angle) for these two samples. As already mentioned, a
dependence of DS,app on q2 is generally another indication of
polydispersity (in addition to the μ2 value). As in the case of
POS-NH2, for PEG@POS-NH2 this observation can also be
correlated to agglomeration of a minor fraction of the particles.
Although sterically stabilized colloids are generally assumed
not to agglomerate, the polymer chains might entangle due to
polymer–polymer and polymer–solvent interactions resulting in
loose entanglements of the colloidal particles.
Quaternization of the remaining secondary amine groups of the
PEGylated particles with ethyliodide or 2-iodoethanol leads to
an increase of the inter-particle repulsive forces. Therefore, the
samples PEG@POS-NH2Q1 and PEG@POS-NH2Q2, as
expected, decreased in size. The measurement of the hydrody-
namic radii of these samples yielded 18.9 nm and 21.4 nm, for
PEG@POS-NH2Q1 and PEG@POS-NH2Q2, respectively. This
decrease is caused by a loosening of the above described entan-
glements. In contrast to the observation of entanglements under
non-physiological conditions, an improved stability could be
verified under physiological conditions for the PEGylated
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samples, as described below. After PEGylation, the zeta poten-
tial drops from +30 mV to ca. +15 mV. The explanation for this
observation is that the additional PEG layer leads to a shielding
of the underlying positive charges.
Characterization under physiological conditions
A characteristic feature of biologically relevant media is a rela-
tively high salinity which could have an impact on the colloidal
stability of nanomaterials. As high salinity leads to a screening
of surface charges, it diminishes electrostatic repulsion between
NPs. In this context, the Debye-length scale is an important
value describing the distance of electrostatic interactions
between colloids. At physiological salt concentrations (at
approximately 150 mM salinity), the Debye length is of the
order of 0.8 nm (for symmetric electrolytes such as sodium
chloride). This leads to coagulation of exclusively electrostati-
cally stabilized nanoparticles in physiological media [78-80].
NexSil20: Table 1 shows the hydrodynamic radius of NexSil20
in presence of RPMI1640 cell medium as determined by DLS.
A hydrodynamic radius of 17.6 nm was obtained in absence of
proteins, which is in good agreement with the measurements in
water with low salinity. The measurement was performed
15 minutes after sample preparation and repeated after 48 h
(data not shown), not displaying any change of the hydrody-
namic properties. Hence, the sample did not give evidence of
agglomeration even under physiological salinity. The high
stability of silica NPs can be attributed to a "gel-like" layer on
the surface of the particles, which is discussed in the literature
as sterically stabilizing coating [81].
With regard to in vivo and in vitro studies, NexSil20 was also
characterized in the presence of serum proteins. RPMI1640 cell
medium supplemented with fetal calf serum (FCS, 5 vol %) was
applied as a model medium. DLS reveals an average hydrody-
namic radius of 9 nm (and a μ2 value of 0.16) for the protein
mixture, describing the presence of a large number of proteins
with variable sizes. In contrast to the fact that the silica parti-
cles are sufficiently stabilized in the absence of biomolecules,
these proteins induce the agglomeration of silica NPs yielding
an average hydrodynamic radius of 91 nm for the agglomerates.
To derive agglomerate sizes in the cases in which proteins were
present, DLS data were evaluated by the so-called multicompo-
nent analysis [28]. By this procedure, the measured autocorrela-
tion function is subdivided into single components with each
component again expressed as a discrete autocorrelation func-
tion. As the autocorrelation functions of single components
cannot be determined by a DLS measurement of the mixture of
components, discrete correlation functions can only be obtained
from measurements of the isolated substances. DLS data evalu-
ation of the mixture of substances is then used to reveal the rela-
tive amplitudes of the single components as well as the size of
the aggregate fraction.
As an example, the multicomponent analysis of the mixture of
serum proteins (FCS), amorphous silica nanoparticles (NP) and
the subsequently formed agglomerates at a scattering angle of
30° is shown in Figure 3. The autocorrelation function of pris-
tine nanoparticles as well as that of the serum proteins were
measured before and thus are preassigned. As result of the
multicomponent analysis, the autocorrelation function of the
mixture can be described as the autocorrelation function of
serum proteins with an amplitude of 0.01 plus the autocorrela-
tion function of pristine nanoparticles with an amplitude of 0.08
plus one additional component with an amplitude of 0.91,
which can be assigned to agglomerates. The relaxation time of
the aggregate component corresponds to a hydrodynamic radius
of 91 nm.
Figure 3: Multicomponent analysis [28] to evaluate the DLS measure-
ment of the mixture of amorphous silica nanoparticles (NP) and serum
proteins (FCS) at a scattering angle of 30°. As serum proteins (green),
pristine nanoparticles (blue) and an additional fraction of agglomer-
ates (red) contribute to the measured autocorrelation function g1(τ)
(black crosses), the combined fitting function (black) also comprises
contributions of these three components. The corresponding ampli-
tudes are 0.01, 0.08 and 0.91, respectively.
As shown, the multicomponent analysis yields not only a size
that can be assigned specifically to the aggregate fraction (in
contrast to standard DLS data evaluation, which only yields a
mean value), but it also allows a closer look at the contribu-
tions of the protein, particle and aggregate components to the
scattering intensity. For the sample discussed above, this reveals
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that more than 90% of the scattered light at a scattering angle of
30° is caused by the agglomerates. The particle component
contributes 8% and the protein component is almost negligible
with an amplitude of less than 1%. The analysis of scattering
intensity contributions for the other measurements that are
described within this publication yielded comparable values.
For larger agglomerates, the contribution of the agglomerate
component reached even higher values in the range of 95%.
Focusing not on the determination of absolute sizes but rather
on a distribution analysis, AF-FFF was used for qualitative
distribution analysis of the agglomerates. Figure 4 shows
elugrams of NexSil20, prepared in RPMI cell medium as well
as in RPMI + 5% FCS. In the upper graph, the scattering inten-
sity signal at an angle of 90° is plotted. As derived by the multi-
component analysis, agglomerates can be detected very well by
light scattering, exhibiting more than 90% of the total ampli-
tude in the DLS experiment. In contrast, the scattering intensity
of proteins was found to be negligible at the concentrations
applied here. Therefore, UV absorbance at a wavelength of
280 nm was additionally measured because it provides a sensi-
tive detection of proteins (lower graph).
Figure 4: AF-FFF fractograms for NexSil20. Blue: NexSil20 prepared
in RPMI cell medium; Red: NexSil20 prepared in RPMI cell medium in
presence of 5 vol % FCS. The AF-FFF channel (ConSenxus) was
operated with a cross flow of 2.5 mL/min and a detector flow of
1 mL/min, with a polysulfone membrane and a spacer of 190 μm thick-
ness, and with an eluate concentration of 200 mg/mL NaN3 in deion-
ized water.
In absence of serum proteins (blue lines) NexSil20 elutes as a
sharp fraction indicating a narrow size distribution. Since scat-
tering of light inside the UV absorbance cell distorts the
absorbance detection, the silica particles cause an apparent UV
absorbance signal despite the fact that they do not carry any
chromophore groups. In the presence of serum proteins (red
lines) a peak for the pristine NPs is observable by light scat-
tering detection. This indicates that the single particles are not
completely depleted. A shift in elution volume denotes the for-
mation of the protein corona. Nevertheless, the use of this data
for size determination would result in arbitrary results due to the
fact that the surface properties are altered by protein adsorption.
Additionally, a broad fraction was detected eluting at later
elution volumes. Since in AF-FFF a sample is fractionated
according to the hydrodynamic size in the order from small to
large particles, this fraction corresponds to large agglomerates
and it reveals a broad size distribution of the agglomerates. As
UV absorbance at 280 nm is sensitive for proteins, the
pronounced UV absorbance signal at the beginning of the
elution process corresponds to the elution of the unbound
proteins. This signal is part of the so-called void peak, which is
an artifact of the method. The void peak represents non-frac-
tioned components such as proteins, which are too small and
elude from retention. Summarizing these observations, AF-FFF
not only confirms the DLS results, but additionally yields a
qualitative insight into the size distribution.
POS-NH2: As POS particles exhibit different surface prop-
erties compared to NexSil20, they also show different agglom-
eration behavior. The electrostatically stabilized samples
POS-NH2, POS-NH2Q1 and POS-NH2Q2 macroscopically pre-
cipitated in RPMI cell medium due to an inefficient stabiliza-
tion. During the sample preparation for DLS, the agglomerates
were completely removed by the necessary sample filtration
[26], therefore, a measurement was not possible. In the pres-
ence of serum proteins, the precipitation could not be observed
by eye. Thus, the samples were filtrated after mixing and
measured with DLS. The resulting hydrodynamic radius was
130 nm for the non-quaternized sample POS-NH2 and approxi-
mately 200 nm for the quaternized samples POS-NH2Q1 and
POS-NH2Q2. In Table 1 these values are given in brackets
since a loss of material due to the filtration process is likely
(especially for the quaternized samples). Although the addition
of serum proteins and the subsequent formation of a protein
corona leads to an increase in colloidal stability of the electro-
statically stabilized POS nanoparticles, in general, those parti-
cles offer poor colloidal stability under physiological condi-
tions.
PEG@POS-NH2: In contrast to the electrostatically stabilized
poly(organosiloxane) NPs, a hydrodynamic radius of 18.6 nm
was detected for the sample PEG@POS-NH2 in RPMI medium.
Additionally, this result and the μ2 value of 0.13 differs from
the hydrodynamic size obtained in distilled water for this
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sample. In that case, the correlation function was superposed by
polymer entanglements leading to loose agglomerates.
Inter-particle polymer entanglements are mainly related to
polymer–solvent  interact ions,  as  descr ibed by the
Flory–Huggins parameter, and solvent quality changes with
salinity due to the solvation shell around ions. As a qualitative
observation, the entanglements of the sample PEG@POS-NH2
dissolve at physiological ion strengths. In the presence of
proteins, agglomerates can be detected, however, they are much
smaller in size than the electrostatically stabilized particles.
The quaternized and PEGylated samples PEG@POS-NH2Q1
and PEG@POS-NH2Q2 exhibit peculiar properties at physio-
logical salinity. Analogous to the non-quaternized sterically
stabilized sample, a hydrodynamic size similar to that of the
pristine particles would be expected. However, radii of approxi-
mately 110 nm were measured, which suggests the formation of
agglomerates or, since the particles are sterically stabilized, the
formation of entanglements. In the presence of proteins, multi-
component analysis yields a hydrodynamic radius of 57 nm and
69 nm for the aggregate component. As these sizes are not
superposed by the scattering signal of proteins, this observation
gives evidence of a reduced diameter for the samples
PEG@POS-NH2Q1 and PEG@POS-NH2Q2 in presence of
proteins. For silver NPs, an additional sterical stabilization
effect induced by protein adsorption was previously reported
[82]. We assume that the stabilization of POS particles in the
presence of proteins is driven by a similar stabilization mecha-
nism.
Summary of results
SiO2-based nanomaterials were characterized with respect to
their size under non-physiological and physiological conditions
by combining results from transmission electron microscopy,
dynamic light scattering and asymmetric flow field-flow frac-
tionation. Differences in the agglomeration state and therefore
in the effective size of the materials were observed and related
to surface properties. In particular, negatively charged silica
nanoparticles were shown to be remarkably stable at physiolog-
ical salinity, though unstable in the presence of proteins. In
contrast, electrostatically stabilized poly(organosiloxane) parti-
cles with a positively charged surface macroscopically precipi-
tated under physiological salinity. The presence of proteins
inhibited the macroscopic precipitation, however, larger
agglomerates still formed. The addition of a poly(ethylene
glycol) coating onto the siloxane NPs yielded sufficient stability
at higher ionic strengths. In presence of serum proteins, only
small amounts of agglomerates could be detected. However, the
alkylation of the secondary amine groups results in a signifi-
cant growth of the hydrodynamic size at physiological salinity.
In presence of serum proteins a dissipation of the agglomerates
was observed. Thus, the increase in diameter in the absence of
proteins is considered to be due to loose inter-particle entangle-
ments of the polymer coating.
In summary, we demonstrated that the variation of the surface
properties of SiO2-based nanoparticles directly affects the
agglomeration behavior under non-physiological as well as
physiological conditions. This behavior is particularly relevant
for biomedical applications since it shows that particles that are
precisely defined in size in deionized water or at low salt
concentrations can become agglomerated and less defined under
physiological conditions.
Conclusion
The physiological impact of a nanomaterial is mainly deter-
mined by three factors. The first one is the question of how the
nanomaterial interacts with biological barriers. Here, interac-
tions with the alveolar surfactant film are of special interest,
because it is the first biological barrier after exposure via the
lung. Therefore, the mechanisms behind the penetration of
hydrophobic siloxane NPs through this barrier were examined
[71-73]. The second factor influencing the physiological impact
of a nanomaterial is the formation of a protein corona. For silica
NPs that exhibit amine and carboxy functionalities it could be
shown that, depending on surface functionalities, the compos-
ition of the protein corona differs drastically [12]. The third
factor is the influence of the protein corona-coated particle on
interactions with the cellular membrane, and therefore, on
cellular responses [14,83]. For example, negatively charged
silica NPs were shown to exhibit a dose-dependent cytotoxicity,
whereas PEGylated poly(organosiloxane) NPs do not reduce the
cell viability [16].
As emphasized in the introductory part of the results section,
verification of the nanomaterial properties in biologically rele-
vant media is crucial to correlate the particle characteristics to
the biological responses that these particles induce. With the
work presented here, a well-characterized system of SiO2-based
nanomaterials is exhibited which allows for variations in
surface properties (surface charge and polarity) as well as in the
mechanism of colloidal stabilization (electrostatically and steri-
cally stabilized). Therefore, combining amine-functionalized
siloxane NPs with silica NPs yields an appropriate model
system to investigate how the surface properties of NPs influ-
ence the interactions of NPs with biological barriers, the forma-
tion of a protein corona and cellular responses.
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